AAPL349.73+1.51 (+0.43%) ▲|ABBV283.49-1.45 (-0.51%) ▼|ABT102.40-0.12 (-0.11%) ▼|ACN245.90-12.84 (-4.96%) ▼|ADBE266.96-3.59 (-1.33%) ▼|AMAT376.93+1.35 (+0.36%) ▲|AMD516.69+8.76 (+1.72%) ▲|AMGN440.77-6.51 (-1.46%) ▼|AMT192.35+10.78 (+5.94%) ▲|AMZN248.56-1.82 (-0.73%) ▼|AVGO324.87+1.63 (+0.50%) ▲|AXP315.83-9.34 (-2.87%) ▼|BA185.04-2.51 (-1.34%) ▼|BAC50.68-0.40 (-0.78%) ▼|BKNG157.29-3.81 (-2.37%) ▼|BLK1,121.22-16.08 (-1.41%) ▼|BMY61.77-1.23 (-1.95%) ▼|BNY144.11-1.21 (-0.83%) ▼|BRK-B545.91-1.07 (-0.19%) ▼|C120.89-1.62 (-1.32%) ▼|CAT683.80-20.26 (-2.88%) ▼|CL94.85-2.55 (-2.61%) ▼|CMCSA22.81-0.03 (-0.13%) ▼|COF200.80-2.64 (-1.30%) ▼|COP150.53+4.90 (+3.36%) ▲|COST1,010.61-7.60 (-0.75%) ▼|CRM245.87-4.43 (-1.77%) ▼|CSCO105.68+0.79 (+0.75%) ▲|CVS93.66-0.82 (-0.87%) ▼|CVX230.56+3.88 (+1.71%) ▲|DE635.53-8.10 (-1.26%) ▼|DHR226.74-3.01 (-1.31%) ▼|DIS112.11-1.02 (-0.90%) ▼|DUK124.40-1.01 (-0.80%) ▼|EMR158.70-1.59 (-0.99%) ▼|FDX296.83-7.10 (-2.33%) ▼|GD346.85-3.95 (-1.12%) ▼|GE284.21-9.33 (-3.18%) ▼|GEV807.01-20.41 (-2.47%) ▼|GILD156.36-0.84 (-0.53%) ▼|GM75.19-2.02 (-2.62%) ▼|GOOG320.81+0.05 (+0.01%) ▲|GOOGL323.99-0.23 (-0.07%) ▼|GS882.41-8.89 (-1.00%) ▼|HD319.03-8.70 (-2.65%) ▼|HON212.59-5.72 (-2.62%) ▼|IBM252.08-0.03 (-0.01%) ▼|INTC86.50+1.01 (+1.18%) ▲|INTU349.29-5.62 (-1.58%) ▼|ISRG452.05+8.20 (+1.85%) ▲|JNJ263.59-4.03 (-1.50%) ▼|JPM331.33-5.21 (-1.55%) ▼|KO93.27-2.08 (-2.18%) ▼|LIN505.84-4.52 (-0.89%) ▼|LLY1,277.92-28.77 (-2.20%) ▼|LMT593.98+4.07 (+0.69%) ▲|LOW198.83-5.55 (-2.71%) ▼|LRCX227.65-2.51 (-1.09%) ▼|MA623.08-10.14 (-1.60%) ▼|MCD248.54-4.09 (-1.62%) ▼|MDLZ63.93-1.26 (-1.93%) ▼|MDT95.79-0.80 (-0.83%) ▼|META644.37-4.48 (-0.69%) ▼|MMM170.98-4.58 (-2.61%) ▼|MO75.18-0.89 (-1.17%) ▼|MRK144.14-3.10 (-2.10%) ▼|MS181.46-2.52 (-1.37%) ▼|MSFT523.07+1.99 (+0.38%) ▲|MU881.87+25.38 (+2.96%) ▲|NEE81.43-0.48 (-0.58%) ▼|NFLX67.03-0.02 (-0.03%) ▼|NKE37.49-0.83 (-2.17%) ▼|NOW155.52-1.48 (-0.94%) ▼|NVDA212.66+0.45 (+0.21%) ▲|ORCL126.20+0.66 (+0.52%) ▲|PEP135.89-2.94 (-2.12%) ▼|PFE29.90-0.52 (-1.71%) ▼|PG162.04-2.46 (-1.50%) ▼|PLTR194.70-1.50 (-0.76%) ▼|PM201.34-0.40 (-0.20%) ▼|QCOM173.80+0.97 (+0.56%) ▲|RTX190.57-4.14 (-2.13%) ▼|SBUX101.23-0.68 (-0.67%) ▼|SCHW90.31-1.13 (-1.24%) ▼|SO93.14-0.69 (-0.73%) ▼|SPG211.43-0.61 (-0.29%) ▼|T21.53-1.22 (-5.34%) ▼|TMO667.70-8.84 (-1.31%) ▼|TMUS152.48-6.32 (-3.98%) ▼|TSLA372.08-2.51 (-0.67%) ▼|TXN281.50+2.00 (+0.72%) ▲|UBER67.71-1.36 (-1.97%) ▼|UNH421.78-3.21 (-0.75%) ▼|UNP289.88-8.22 (-2.76%) ▼|UPS99.36-2.16 (-2.13%) ▼|USB59.13-0.89 (-1.48%) ▼|V407.29-7.05 (-1.70%) ▼|VZ43.92-1.28 (-2.83%) ▼|WFC82.00-1.01 (-1.22%) ▼|WMT120.23-0.89 (-0.73%) ▼|XOM181.49+3.26 (+1.83%) ▲|AAPL349.73+1.51 (+0.43%) ▲|ABBV283.49-1.45 (-0.51%) ▼|ABT102.40-0.12 (-0.11%) ▼|ACN245.90-12.84 (-4.96%) ▼|ADBE266.96-3.59 (-1.33%) ▼|AMAT376.93+1.35 (+0.36%) ▲|AMD516.69+8.76 (+1.72%) ▲|AMGN440.77-6.51 (-1.46%) ▼|AMT192.35+10.78 (+5.94%) ▲|AMZN248.56-1.82 (-0.73%) ▼|AVGO324.87+1.63 (+0.50%) ▲|AXP315.83-9.34 (-2.87%) ▼|BA185.04-2.51 (-1.34%) ▼|BAC50.68-0.40 (-0.78%) ▼|BKNG157.29-3.81 (-2.37%) ▼|BLK1,121.22-16.08 (-1.41%) ▼|BMY61.77-1.23 (-1.95%) ▼|BNY144.11-1.21 (-0.83%) ▼|BRK-B545.91-1.07 (-0.19%) ▼|C120.89-1.62 (-1.32%) ▼|CAT683.80-20.26 (-2.88%) ▼|CL94.85-2.55 (-2.61%) ▼|CMCSA22.81-0.03 (-0.13%) ▼|COF200.80-2.64 (-1.30%) ▼|COP150.53+4.90 (+3.36%) ▲|COST1,010.61-7.60 (-0.75%) ▼|CRM245.87-4.43 (-1.77%) ▼|CSCO105.68+0.79 (+0.75%) ▲|CVS93.66-0.82 (-0.87%) ▼|CVX230.56+3.88 (+1.71%) ▲|DE635.53-8.10 (-1.26%) ▼|DHR226.74-3.01 (-1.31%) ▼|DIS112.11-1.02 (-0.90%) ▼|DUK124.40-1.01 (-0.80%) ▼|EMR158.70-1.59 (-0.99%) ▼|FDX296.83-7.10 (-2.33%) ▼|GD346.85-3.95 (-1.12%) ▼|GE284.21-9.33 (-3.18%) ▼|GEV807.01-20.41 (-2.47%) ▼|GILD156.36-0.84 (-0.53%) ▼|GM75.19-2.02 (-2.62%) ▼|GOOG320.81+0.05 (+0.01%) ▲|GOOGL323.99-0.23 (-0.07%) ▼|GS882.41-8.89 (-1.00%) ▼|HD319.03-8.70 (-2.65%) ▼|HON212.59-5.72 (-2.62%) ▼|IBM252.08-0.03 (-0.01%) ▼|INTC86.50+1.01 (+1.18%) ▲|INTU349.29-5.62 (-1.58%) ▼|ISRG452.05+8.20 (+1.85%) ▲|JNJ263.59-4.03 (-1.50%) ▼|JPM331.33-5.21 (-1.55%) ▼|KO93.27-2.08 (-2.18%) ▼|LIN505.84-4.52 (-0.89%) ▼|LLY1,277.92-28.77 (-2.20%) ▼|LMT593.98+4.07 (+0.69%) ▲|LOW198.83-5.55 (-2.71%) ▼|LRCX227.65-2.51 (-1.09%) ▼|MA623.08-10.14 (-1.60%) ▼|MCD248.54-4.09 (-1.62%) ▼|MDLZ63.93-1.26 (-1.93%) ▼|MDT95.79-0.80 (-0.83%) ▼|META644.37-4.48 (-0.69%) ▼|MMM170.98-4.58 (-2.61%) ▼|MO75.18-0.89 (-1.17%) ▼|MRK144.14-3.10 (-2.10%) ▼|MS181.46-2.52 (-1.37%) ▼|MSFT523.07+1.99 (+0.38%) ▲|MU881.87+25.38 (+2.96%) ▲|NEE81.43-0.48 (-0.58%) ▼|NFLX67.03-0.02 (-0.03%) ▼|NKE37.49-0.83 (-2.17%) ▼|NOW155.52-1.48 (-0.94%) ▼|NVDA212.66+0.45 (+0.21%) ▲|ORCL126.20+0.66 (+0.52%) ▲|PEP135.89-2.94 (-2.12%) ▼|PFE29.90-0.52 (-1.71%) ▼|PG162.04-2.46 (-1.50%) ▼|PLTR194.70-1.50 (-0.76%) ▼|PM201.34-0.40 (-0.20%) ▼|QCOM173.80+0.97 (+0.56%) ▲|RTX190.57-4.14 (-2.13%) ▼|SBUX101.23-0.68 (-0.67%) ▼|SCHW90.31-1.13 (-1.24%) ▼|SO93.14-0.69 (-0.73%) ▼|SPG211.43-0.61 (-0.29%) ▼|T21.53-1.22 (-5.34%) ▼|TMO667.70-8.84 (-1.31%) ▼|TMUS152.48-6.32 (-3.98%) ▼|TSLA372.08-2.51 (-0.67%) ▼|TXN281.50+2.00 (+0.72%) ▲|UBER67.71-1.36 (-1.97%) ▼|UNH421.78-3.21 (-0.75%) ▼|UNP289.88-8.22 (-2.76%) ▼|UPS99.36-2.16 (-2.13%) ▼|USB59.13-0.89 (-1.48%) ▼|V407.29-7.05 (-1.70%) ▼|VZ43.92-1.28 (-2.83%) ▼|WFC82.00-1.01 (-1.22%) ▼|WMT120.23-0.89 (-0.73%) ▼|XOM181.49+3.26 (+1.83%) ▲|
10.7 C
New York
Friday, October 23, 2026

Tag: Canada

newsFORsourcecompanycontentinformation1releasesmarket

Transaction in Own Shares

Transaction in Own Shares

Dr Benoit Benoit Orthopedic Clinic: A New Vision of Personalized Surgical Care in Canada

Experienced Surgeon, Compassionate Team, Whole-Person Care. MONTREAL, July 18, 2025 /CNW/ - As access to care becomes increasingly complex, the Dr Benoit Benoit Orthopedic Clinic,...

European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms – 
– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms – 
– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

DuraServ Acquires Overhead Door & Fireplace of Montgomery

This latest partnership expands the commercial overhead, residential garage door, and fireplace services available to customers in the Central Alabama area DALLAS, July 18, 2025...

Media Advisory – PS Hogan to Announce Investments in Alberta’s Forests

CALGARY, AB, July 18, 2025 /CNW/ - Corey Hogan, Parliamentary Secretary to the Minister of Energy and Natural Resources, will announce investments to help...

Timbercreek Financial Announces Conference Call to Discuss Second Quarter Financial Results

TORONTO, July 18, 2025 (GLOBE NEWSWIRE) -- Timbercreek Financial (TSX: TF) will hold a conference call and live audio webcast at 1:00 p.m. (ET) on Thursday, July 31, 2025, to discuss financial results for the quarter ended June 30, 2025. The financial results will be released on Wednesday, July 30, 2025, after the markets close. Interested parties are invited to participate in the call with management which will be followed by a question and answer period with analysts.

Sleep Apnea Devices Market worth $11.6 billion by 2032 with 7.6% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., July 18, 2025 /PRNewswire/ -- The global Sleep Apnea Devices Market, valued at US$6.4 billion in 2024 stood at US$6.9 billion in 2025...

Sleep Apnea Devices Market worth $11.6 billion by 2032 with 7.6% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., July 18, 2025 /PRNewswire/ -- The global Sleep Apnea Devices Market, valued at US$6.4 billion in 2024 stood at US$6.9 billion in 2025...

EURneffy® (adrenaline nasal spray) Approved in the U.K. as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)

EURneffy (neffy® in the U.S.) offers a new delivery method for adrenaline in the U.K. for adults and children (>30 kg) living with severe allergic reactions

KEEN Encourages Fans to ‘Run for the Trails’

New Seek trail runner brings KEEN's iconic comfort and durability into trail running with longer-lasting cushioning and traction. BRAMPTON, ON, July 18, 2025 /CNW/ -...

Spire to host FY25 third quarter earnings conference call on August 5

ST. LOUIS, July 18, 2025 /PRNewswire/ -- Spire Inc. (NYSE: SR) will host a conference call and webcast on Tuesday, August 5 to discuss...

Tariffs and Expiring Federal EV Tax Credits Fuel Affordability Challenges in Auto After H1 Sales Boom, According to Cars Commerce’s Industry Insights Report

Imported Vehicle Prices Rise While U.S.-built Vehicles Drop $200 on Average CHICAGO, July 18, 2025 /PRNewswire/ -- Cars.com Inc. (NYSE: CARS) (d/b/a "Cars Commerce...

Ensign Energy Services Inc. – Second Quarter 2025 Earnings Conference Call and Webcast

CALGARY, AB, July 18, 2025 /CNW/ - Ensign Energy Services Inc. ("Ensign" or "the Company") is scheduled to release its second quarter 2025 results...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCanada

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers